BIO.B Bio Rad Laboratories Inc

On August 27, 2019, Bio-Rad Laboratories, Inc. posted a corrected press release (“New Release”) on its website announcing the Company’s financial results for the quarter ended June 30, 2019. The New Release was issued solely to correct the non-GAAP results in the press release issued on August 1, 2019 (“Original Release”) which inadvertently stated that the Legal Matters related expense in the three and six months ended June 30, 2019 was $3.37 million higher than the correct amount. This error resulted in immaterial changes, in the Company’s view, for the three and the six months ended June 30, 2019 to the following non-GAAP results provided in the Original Release: Non-GAAP selling, general and administrative expense; Non-GAAP income from operations; Non-GAAP income before income taxes; Non-GAAP provision for income taxes; Non-GAAP net income; Non-GAAP diluted income per share; Non-GAAP operating Margin; and Non-GAAP effective tax rate. The Company has prepared and furnished, as Exhibit 99.1 to this Amendment, a corrected earnings release which includes the corrected information. The corrections to these non-GAAP results did not impact the Company’s GAAP results reported in the Original Release and did not change the Company’s guidance that it provided in the Original Release. A copy of the corrected earnings release is furnished as Exhibit 99.1 to this Amendment and is incorporated herein by reference.

In accordance with General Instruction B.2 of Form 8-K, the information in this Amendment, including Exhibit 99.1 attached hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.